Soleno Therapeutics Management

How experienced are the management team and are they aligned to shareholders interests?

5.7yrs

Average management tenure


CEO

Anish Bhatnagar (52 yo)

8.5yrs

Tenure

US$4,375,442

Compensation

Dr. Anish Bhatnagar, M.D. has been Chief Executive Officer and Director of Soleno Therapeutics, Inc. since February 6, 2014 and serves as its President and Chief Operating Officer. Dr. Bhatnagar served as...


CEO Compensation Analysis

Anish Bhatnagar's Compensation vs Soleno Therapeutics Earnings
How has Anish Bhatnagar's remuneration changed compared to Soleno Therapeutics's earnings?
DateTotal Comp.SalaryCompany Earnings
Jun 30 2022n/an/a

-US$23m

Mar 31 2022n/an/a

-US$28m

Dec 31 2021US$4mUS$538k

-US$31m

Sep 30 2021n/an/a

-US$31m

Jun 30 2021n/an/a

-US$31m

Mar 31 2021n/an/a

-US$28m

Dec 31 2020US$3mUS$504k

-US$25m

Sep 30 2020n/an/a

-US$36m

Jun 30 2020n/an/a

-US$27m

Mar 31 2020n/an/a

-US$30m

Dec 31 2019US$822kUS$470k

-US$31m

Sep 30 2019n/an/a

-US$16m

Jun 30 2019n/an/a

-US$19m

Mar 31 2019n/an/a

-US$16m

Dec 31 2018US$952kUS$460k

-US$12m

Sep 30 2018n/an/a

-US$16m

Jun 30 2018n/an/a

-US$17m

Mar 31 2018n/an/a

-US$13m

Dec 31 2017US$1mUS$446k

-US$12m

Sep 30 2017n/an/a

-US$13m

Jun 30 2017n/an/a

-US$11m

Mar 31 2017n/an/a

-US$9m

Dec 31 2016US$959kUS$460k

-US$10m

Sep 30 2016n/an/a

-US$8m

Jun 30 2016n/an/a

-US$10m

Mar 31 2016n/an/a

-US$7m

Dec 31 2015US$1mUS$435k

-US$10m

Compensation vs Market: Anish's total compensation ($USD4.38M) is above average for companies of similar size in the US market ($USD772.00K).

Compensation vs Earnings: Anish's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: SLNO's management team is seasoned and experienced (5.7 years average tenure).


Board Members

Experienced Board: SLNO's board of directors are considered experienced (6 years average tenure).